The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
R. Salazar
No relevant relationships to disclose
R. Rosenberg
No relevant relationships to disclose
M. Lutke Holzik
No relevant relationships to disclose
J. Marshall
No relevant relationships to disclose
J. J. M. Van Der Hoeven
No relevant relationships to disclose
B. Glimelius
No relevant relationships to disclose
F. Bibeau
No relevant relationships to disclose
L. Stork-Sloots
Employment or Leadership Position - Agendia
R. A. Bender
Employment or Leadership Position - Agendia
J. Capdevila
No relevant relationships to disclose